Skip to content

Clinical trials

Expanded access trials in Brazil

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Expanded access Country / region: Brazil Clear all

31 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20051
20062
20081
20141

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
No longer available17
Approved for marketing12
Available2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bristol-Myers Squibb3
Janssen Research & Development, LLC3
Novartis Pharmaceuticals3
Amgen2
Boehringer Ingelheim2
Eli Lilly and Company2
Janssen-Cilag Farmaceutica Ltda.2
Pfizer2
Aragon Pharmaceuticals, Inc.1
Astellas Pharma Global Development, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Prostatic Neoplasms3
Carcinoma, Non-Small-Cell Lung2
Recurrence2
Adenocarcinoma1
Anemia, Sickle Cell1
Bites and Stings1
Breast Neoplasms1
Carcinoma, Renal Cell1
Chronic Pain1
Crohn Disease1

Trials

Showing 1 to 25 of 31. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.